Pulmonary Mucormycosis Presenting as Rapidly Progressive Cavitary Pneumonia and Lung Abscess in a Patient With Type 2 Diabetes Mellitus and a Solitary Functioning Kidney: A Report of a Rare Case

Pulmonary mucormycosis is an invasive fungal infection that can present with rapidly progressive pulmonary disease and may mimic bacterial pneumonia or lung abscess. This diagnostic overlap can lead to delayed recognition and treatment. We report the case of a 33-year-old woman with type 2 diabetes mellitus and a solitary functioning kidney, who presented with fever, productive cough, pleuritic chest pain, and progressive dyspnea. Serial chest radiographs demonstrated rapid progression of lung lesions from right-sided consolidation to cavitary necrosis with air-fluid level formation, consistent with lung abscess. Despite broad-spectrum antibiotic therapy, clinical and inflammatory markers worsened, prompting bronchoscopy evaluation. Histopathology revealed broad aseptate fungal hyphae with right-angle branching. Fungal culture confirmed Rhizopus species, compatible with the diagnosis of pulmonary mucormycosis. The patient was treated with intravenous liposomal amphotericin B for six weeks. The therapy was complicated by amphotericin-induced hypokalemia, hypomagnesemia, and transient liver enzyme derangement, necessitating close monitoring given her solitary functioning kidney. She demonstrated gradual clinical and biochemical improvement with appropriate antifungal therapy. This case highlights the importance of early suspicion of mucormycosis in diabetic patients with non-resolving pneumonia and underscores the challenges of managing antifungal therapy in patients with limited renal reserve.

Authors

Publication Details

Journal
Cureus
Published
2026-04-27
DOI
https://doi.org/10.7759/cureus.107813
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary Mucormycosis Presenting as Rapidly Progressive Cavitary Pneumonia and Lung Abscess in a Patient With Type 2 Diabetes Mellitus and a Solitary Functioning Kidney: A Report of a Rare Case

Pakkiyaretnam Mayurathan, Rumanas Lafeer
Cureus
Antifungal resistance and susceptibility
article

Pulmonary Mucormycosis Presenting as Rapidly Progressive Cavitary Pneumonia and Lung Abscess in a Patient With Type 2 Diabetes Mellitus and a Solitary Functioning Kidney: A Report of a Rare Case

Pakkiyaretnam Mayurathan, Rumanas Lafeer
article en

Abstract

Pulmonary mucormycosis is an invasive fungal infection that can present with rapidly progressive pulmonary disease and may mimic bacterial pneumonia or lung abscess. This diagnostic overlap can lead to delayed recognition and treatment. We report the case of a 33-year-old woman with type 2 diabetes mellitus and a solitary functioning kidney, who presented with fever, productive cough, pleuritic chest pain, and progressive dyspnea. Serial chest radiographs demonstrated rapid progression of lung lesions from right-sided consolidation to cavitary necrosis with air-fluid level formation, consistent with lung abscess. Despite broad-spectrum antibiotic therapy, clinical and inflammatory markers worsened, prompting bronchoscopy evaluation. Histopathology revealed broad aseptate fungal hyphae with right-angle branching. Fungal culture confirmed Rhizopus species, compatible with the diagnosis of pulmonary mucormycosis. The patient was treated with intravenous liposomal amphotericin B for six weeks. The therapy was complicated by amphotericin-induced hypokalemia, hypomagnesemia, and transient liver enzyme derangement, necessitating close monitoring given her solitary functioning kidney. She demonstrated gradual clinical and biochemical improvement with appropriate antifungal therapy. This case highlights the importance of early suspicion of mucormycosis in diabetic patients with non-resolving pneumonia and underscores the challenges of managing antifungal therapy in patients with limited renal reserve.

Cureus
Good health and well-being
Openalex Percentile: Top 6%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.